by HTLV | May 4, 2022
Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study Abstract Background: Human T-cell Leukemia Virus type-1 (HTLV-1) is a retrovirus that causes two diseases including Adult T-cell...
by HTLV | May 4, 2022
HTLV-1 Disease Abstract The years 2020 and 2021 will remain memorable years for many reasons […]. Click here to access the publication.
by HTLV | May 4, 2022
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines Abstract Human T-cell lymphotropic virus type 1 (HTLV-1) infection affects millions of individuals worldwide and can lead to severe leukemia,...
by HTLV | May 4, 2022
Involvement of EZH2 inhibition in lenalidomide and pomalidomide-mediated growth suppression in HTLV-1-infected cells Abstract Immunomodulatory imide drugs (IMiDs), such as lenalidomide and pomalidomide, exert pleiotropic effects, e.g., antitumor effects in multiple...
by HTLV | May 4, 2022
Polymorphisms in HTLV-1 Tax-responsive elements in HTLV-1-associated myelopathy/tropical spastic paraparesis patients are associated with reduced proviral load but not with disease progression Abstract Human T-lymphotropic virus type 1 (HTLV-1) provirus expression is...
